Introduction
============

Oxazolo\[5,4-*d*\]pyrimidines have been reported to possess a variety of biological activities including kinase inhibition \[[@R1]--[@R2]\], adenosine receptor antagonism \[[@R3]\] and tumor growth inhibition \[[@R4]\]. In particular, 5-aminooxazolo\[5,4-*d*\]pyrimidin-7(6*H*)-ones \[9-oxa-guanines\] and related heterocycles have been shown to inhibit the ability of ricin to inactivate ribosomes \[[@R5]\]. Given these reports, and the expectation of further applications based upon similarity to naturally occurring nucleic acid bases, this heterocyclic ring system continues to generate interest.

Approaches to the oxazolo\[5,4-*d*\]pyrimidine ring system generally involve either cyclodehydration of an 5-(acylamino)-4-hydroxypyrimidine \[[@R6]--[@R10]\] or elaboration of a 4-cyano- or 4-(alkoxycarbonyl)-5-aminooxazole \[[@R11]--[@R15]\] ([Fig. 1](#F1){ref-type="fig"}), with only isolated reports of alternative routes \[[@R16]--[@R17]\]. However, few publications have described the preparation of 5-aminooxazolo\[5,4-*d*\]pyrimidin-7(6*H*)-ones \[[@R5],[@R8],[@R14]\] or 5-mercaptooxazolo\[5,4-*d*\]pyrimidin-7(6*H*)-ones \[9-oxa-2-thio-xanthines\] \[[@R7],[@R15]\], and in both cases, the conditions do not appear to be amenable to the preparation of oxazolo\[5,4-*d*\]pyrimidines with variations at the 2-position, particularly those with additional functional groups or increased steric demand.
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In pursuing 8-methyl-9-oxa-guanine \[2-methyloxazolo\[5,4-*d*\]pyrimidin-7(6*H*)-one\] as an initial lead in the design of inhibitors of the ribosome-inactivating protein ricin \[[@R5]\], we set out to prepare a series of 2-substituted 5-aminooxazolo\[5,4-*d*\]pyrimidin-7(6*H*)-ones and related 5-thio-oxazolo\[5,4-*d*\]pyrimidines. Here we report these studies, which have led to the preparation of analogs suitable for further elaboration, for example by "click" chemistry employing copper-catalyzed Huisgen 1,3-dipolar cycloadditions \[[@R18]\].

Results and Discussion
======================

Our previous route \[[@R5]\] to 8-methyl-9-oxa-guanine (**2a**) involved the thermal cyclodehydration of 5-(acetylamino)-2-amino-4,6-dihydroxypyrimidine (**1a**) \[[@R19]\] ([Fig. 2](#F2){ref-type="fig"}). Unfortunately, for other 5-acylamino analogs of **1a**, this route failed to afford the required oxazolo\[5,4-*d*\]pyrimidines, presumably due to decomposition of the product at the temperatures required for cyclodehydration. Other cyclodehydration conditions (POCl~3~, PPA) were also unsuccessful.

![Thermal cyclodehydration route to 9-oxo-guanine.](Beilstein_J_Org_Chem-04-26-03){#F2}

An alternative route was sought in which the oxazole ring was formed first, followed by elaboration of the pyrimidine ring. Our previous work had demonstrated that in the case of ethyl 5-amino-2-methyloxazole-4-carboxylate **3a** \[[@R20]\], direct annulation with chloroformamidine in DMSO at 120 °C or with 2-methylisothiourea sulfate neat or in ethylene glycol at 170 °C did not afford the oxazolo\[5,4-*d*\]pyrimidine **2** ([Fig. 2](#F2){ref-type="fig"}). Thus, a stepwise annulation \[[@R15]\] strategy was explored for the preparation of analogs of **2** bearing different 2-positions substituents. The required 5-aminooxazoles **3b,c** were prepared from the (acylamino)cyanoacetates **5b,c**, which in turn were derived from ethyl cyanoglyoxylate oxime (**4**) by reduction followed by acylation by isobutyric anhydride or azidoacetyl chloride ([Fig. 3](#F3){ref-type="fig"}). Reaction of the aminooxazoles **3b,c** with benzoylisothiocyanate afforded the thioureas **6b,c**. Direct cyclization of **6b,c** to oxazolo\[5,4-*d*\]pyrimidines **2b,c** by treatment with ammonia in methanol was unsuccessful. However, thioureas **6b,c** were converted to the desired 2-substituted the oxazolo\[5,4-*d*\]pyrimidines **2b,c** by stepwise methylation followed by cyclization in the presence of ammonia in methanol. Although the intermediate products after methylation were not purified, in the case of **6c** the ^1^H NMR spectrum of the crude product following methylation retains the signals for the ethoxy group of **6c** and displays a new resonance for the *S*-methyl group at 2.0 ppm (see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}), indicating that the intermediate is the *S*-methylisothiourea **A** ([Fig. 3](#F3){ref-type="fig"}). The mechanism involved in the conversion of intermediates such as **A** to **2** is not clear. It is unlikely that the 5-(methylthio)oxazolo\[5,4-*d*\]pyrimidine is an intermediate because treatment of 5-(methylthio)oxazolo\[5,4-*d*\]pyrimidine **8a** (see below) with ammonia in methanol fails to afford **2a**.
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The thiourea **6b** and its analog **6a**, which was prepared from aminooxazole **3a** in 51% yield, were also subjected to cyclization in the presence of ethanolic KOH to afford the 5-mercaptooxazolo\[5,4-*d*\]pyrimidin-7(6*H*)-ones **7a,b** ([Fig. 4](#F4){ref-type="fig"}). Further elaboration of **7a** by alkylation with methyl iodide, benzyl bromide, propargyl bromide, or methyl 6-*O*-(tolylsulfonyl)-α-D-glucopyranoside \[[@R21]\] afforded the thioethers **8a**--**d**, respectively. The structural assignment of **8a**--**d** as thioethers rest principally on their ^1^H and ^13^C NMR spectra, which contain resonances more commensurate with groups attached to sulfur (e.g., for **8a**: 2.2 ppm in ^1^H and 13 ppm in ^13^C NMR, respectively) than to nitrogen, as would be the case for 4- or 3-alkylated 5-mercaptooxazolo\[5,4-*d*\]pyrimidine-7(6*H*)-ones.
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The thioether **8c** bearing a propargyl substituent was subjected to "click" chemistry coupling with benzyl azide or 2-morpholinoethyl azide in the presence of catalytic CuSO~4~ and sodium ascorbate to afford the triazoles **9** and **10**, respectively, in good yield ([Fig. 5](#F5){ref-type="fig"}). The copper-catalyzed Huisgen cycloaddition of terminal alkynes and alkyl azides favors formation of the 1,4-triazole regioisomers \[[@R22]\], and in the case of triazole **9**, this regiochemistry was confirmed by ^1^H NOE spectra (see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}).

![Click chemistry elaboration of a 5-(propargylthio)oxazolo\[5,4-*d*\]pyrimidine.](Beilstein_J_Org_Chem-04-26-06){#F5}

Conclusion
==========

In conclusion, routes to functionalized oxazolo\[5,4-*d*\]pyrimidines from 2-substituted 5-aminooxazole-4-carboxylic acid ethyl esters were developed, the key to which is the relatively mild conditions employed in the step-wise elaboration of the pyrimidine ring. Compounds **2b,c**, **7a,b**, **8a**--**d**, **9**, and **10** were evaluated for their ability to inhibit recombinant, catalytically active ricin A-chain (RTA) employing a modification of the previously reported assay \[[@R5]\]. Briefly, the synthesis of protein from endogenous globin mRNA by rabbit reticulocyte lysate was determined in the absence of RTA, in the presence of sufficient RTA to inhibit 90% of protein synthesis (*ca.* 10 pM), and in the presence of both RTA and increasing concentrations of the oxazolo\[5,4-*d*\]pyrimidines. The ability of these compounds to inhibit RTA and thereby rescue protein synthesis was determined. Compounds **2b** (IC~50~ = 2.8 mM) and **9** (IC~50~ = 1.6 mM), displayed some activity; whereas, none of the other compounds examined showed any significant RTA inhibitory activity.
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======================

###### 

This file includes full experimental details for all new compounds.

###### 

Copies of ^1^H and ^13^C NMR spectra of compounds **2b**,**c**; **3a**--**c**; **5b**,**c**; **6a**--**c**; **A**; **7a**,**b**; **8a**--**d**; **9**; and **10**.
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